Ultragenyx Pharma (RARE) January 50 calls active

Ultragenyx Pharma (NASDAQ: RARE) 30-day option implied volatility is at 55; compared to its 52-week range of 40 to 147 with a focus on January 50 calls.

You May Also Be Interested In

• Ferguson Enterprises to Join S&P 500; ADI Global Distribution to Join S&P SmallCap 600
• Gamma Resources plans $880,000 private placement, cancels prior offering
• Veraxa Biotech AG (VRXA) files for 25M share offering by selling stockholders